The availability of weight loss drugs on the NHS doesn’t mean people can give up healthy lifestyles, Health Secretary Wes ...

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

The announcement could shake up the market for such injections, since the shortage designation allowed compounding pharmacies ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...

NHS leaders consider phased roll out of Mounjaro obesity jab to combat high demand - Nearly a quarter of a million people are ...

Compounding pharmacies have used a legal provision that allows them to make knockoff versions of Lilly’s Zepbound and Mounjaro while they are in a shortage. While Lilly has raised questions ...

Digestive side effects are common in people using Mounjaro. One possible digestive side effect is sulfur burps. These burps have a distinct smell similar to rotten eggs. Mounjaro (tirzepatide ...

After referring to the launch of its type 2 diabetes therapy Mounjaro as viral earlier this year, its fourth-quarter sales came as a bit of a disappointment – albeit still setting it up as a ...